SABRIL

This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, France, Hong Kong, Ireland, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug SABRIL contains one active pharmaceutical ingredient (API):

1 Vigabatrin UNII GR120KRT6K - VIGABATRIN

Vigabatrin is a selective irreversible inhibitor of GABA transaminase, the enzyme responsible for the breakdown of GABA (gamma aminobutyric acid). Vigabatrin increases the concentration of GABA, the major inhibitory neurotransmitter in the brain. Read about Vigabatrin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SABRIL Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AG04	Vigabatrin	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives
Discover more medicines within N03AG04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2667J, 2668K
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 576720070081817
Country: CA	Health Products and Food Branch	Identifier(s): 02065819, 02068036
Country: EE	Ravimiamet	Identifier(s): 1116694
Country: FR	Base de données publique des médicaments	Identifier(s): 61139833, 67326875
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 21523, 37117
Country: HK	Department of Health Drug Office	Identifier(s): 35365
Country: IE	Health Products Regulatory Authority	Identifier(s): 44726, 44768, 44970
Country: JP	医薬品医療機器総合機構	Identifier(s): 1139013B1026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1080060, 1080061, 1082649
Country: MT	Medicines Authority	Identifier(s): MA1359/03101
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 460M93
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 31771, 66141
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 5938
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100059220, 100097344
Country: SG	Health Sciences Authority	Identifier(s): 07955P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5933052H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699809090187, 8699809240513
Country: US	FDA, National Drug Code	Identifier(s): 67386-111, 67386-211
Country: ZA	Health Products Regulatory Authority	Identifier(s): 28/2.5/0021